Data / Crowdfunding / New York / Micoy Therapeutics, Inc.
Micoy Therapeutics, Inc.: crowdfunding raise on StartEngine Primary, LLC, $20,000 to $1,234,994 (2025)
Micoy Therapeutics, Inc., a corporation in Brooklyn, NY, filed a Form C with the SEC on January 23, 2025 to raise $20,000 to $1,234,994 in common stock through StartEngine Primary, LLC. The offering closed on April 30, 2025. In its most recent fiscal year it reported $0 in revenue and a net loss of $1,451,848, with 4 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.micoytherapeutics.com
- Funding portal
- StartEngine Primary, LLC
- Address
- 760 PARKSIDE AVENUE, SUITE 206, Brooklyn, NY 11226
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- June 7, 2024
- SEC CIK
- 0002041723
Offering terms
From the amendment filed January 23, 2025.
- Security
- Common Stock
- Price
- $1.75
- Target
- $20,000
- Maximum
- $1,234,994
- Deadline
- April 30, 2025
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-U filed April 16, 2025.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-1,451,848 | $-136,210 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $0 | $0 | sec.gov |
| Cash | $0 | $0 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $0 | $0 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| April 16, 2025 | Progress update | $20,000 | $1,234,994 | April 30, 2025 | At the close of the offering, the issuer closed on $0.00 and 0 number of securities. | sec.gov |
| January 23, 2025 | Amendment | $20,000 | $1,234,994 | April 30, 2025 | Updated valuation & investment perks disclaimers, disclosed CEO concurrent work, lack of salary, related risks, added details on indebtedness, related-party transactions, updated forward-looking statement disclosures on the campaign page. | sec.gov |
| December 5, 2024 | Progress update | $123,999 | $1,234,994 | January 27, 2025 | The issuer has raised over 50% ($85,681.22) of the offering target amount ($123,999.75). | sec.gov |
| October 29, 2024 | Offering | $123,999 | $1,234,994 | January 27, 2025 | sec.gov |
Updated April 16, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.